Handelsbanken Fonder
DXCM icon

Handelsbanken Fonder’s DexCom DXCM Stock Holding History

Handelsbanken Fonder’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6M Sell
262,070
-7,441
-3% -$496K 0.05% 294
2026
Q1 		$16.9M Sell
269,511
-50,613
-16% -$3.52M 0.06% 265
2025
Q4 		$21.2M Sell
320,124
-230,974
-42% -$14.9M 0.06% 253
2025
Q3 		$37.1M Buy
551,098
+66,713
+14% +$5.28M 0.12% 161
2025
Q2 		$42.3M Buy
484,385
+267,118
+123% +$20.9M 0.15% 128
2025
Q1 		$14.8M Buy
217,267
+1,529
+0.7% +$125K 0.06% 274
2024
Q4 		$16.8M Buy
215,738
+51,275
+31% +$3.8M 0.06% 274
2024
Q3 		$11M Sell
164,463
-265,677
-62% -$21.8M 0.04% 336
2024
Q2 		$48.8M Sell
430,140
-21,110
-5% -$2.67M 0.21% 96
2024
Q1 		$62.6M Buy
451,250
+11,259
+3% +$1.42M 0.27% 79
2023
Q4 		$54.6M Sell
439,991
-24,615
-5% -$2.51M 0.27% 83
2023
Q3 		$43.3M Buy
464,606
+45,735
+11% +$5.16M 0.24% 91
2023
Q2 		$53.8M Buy
418,871
+45,001
+12% +$5.44M 0.29% 73
2023
Q1 		$43.4M Sell
373,870
-24,983
-6% -$2.8M 0.25% 93
2022
Q4 		$45.2M Buy
398,853
+19,431
+5% +$2.13M 0.28% 84
2022
Q3 		$30.6M Buy
379,422
+6,958
+2% +$589K 0.2% 120
2022
Q2 		$27.8M Buy
372,464
+119,228
+47% +$10.9M 0.18% 132
2022
Q1 		$32.4M Sell
253,236
-40,352
-14% -$4.41M 0.18% 126
2021
Q4 		$39.4M Sell
293,588
-53,020
-15% -$7.62M 0.19% 126
2021
Q3 		$47.4M Buy
346,608
+17,992
+5% +$2.27M 0.25% 92
2021
Q2 		$35.1M Buy
328,616
+16,900
+5% +$1.62M 0.18% 125
2021
Q1 		$28M Buy
311,716
+4,912
+2% +$461K 0.16% 140
2020
Q4 		$28.4M Buy
306,804
+74,072
+32% +$6.61M 0.17% 132
2020
Q3 		$24M Buy
232,732
+21,600
+10% +$2.26M 0.18% 123
2020
Q2 		$21.4M Buy
211,132
+119,132
+129% +$10.7M 0.18% 126
2020
Q1 		$6.19M Hold
92,000
– – 0.13% 137
2019
Q4 		$5.03M Buy
92,000
+32,000
+53% +$1.52M 0.09% 155
2019
Q3 		$2.24M Buy
+60,000
New +$2.33M 0.05% 164
2017
Q3 		– Sell
-86,000
Closed -$1.57M – 202
2017
Q2 		$1.57M Buy
86,000
+46,000
+115% +$850K 0.04% 153
2017
Q1 		$847K Buy
+40,000
New +$781K 0.02% 160

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Handelsbanken Fonder's DXCM Position: Q2 2026 in Review

Handelsbanken Fonder reduced its DexCom (DXCM) stake by 2.8% in Q2 2026, selling an estimated $496K and leaving 262,070 shares worth $17.6M. The position accounts for 0.05% of the portfolio, ranked #294.

Handelsbanken Fonder first reported a position in DXCM in Q1 2017 and has held it in 30 quarters since. The position peaked at $62.6M in Q1 2024. 577 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Handelsbanken Fonder held 262,070 shares of DexCom worth $17.6M as of Q2 2026.
  • Handelsbanken Fonder sold 7,441 DexCom shares in Q2 2026, an estimated $496K.
  • DexCom made up 0.05% of Handelsbanken Fonder's portfolio in Q2 2026, its #294 holding.
  • Handelsbanken Fonder first reported a position in DexCom in Q1 2017 and has held it in 30 quarters since.
  • Handelsbanken Fonder's DexCom position peaked at $62.6M in Q1 2024.
  • 577 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.